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Mast cell-derived mediators of hypersensitivity include amines, polypeptides, 
and proteoglycans that are present preformed in the granules, as well as metab- 
olites  of arachidonic  acid  and  other  lipids  that  are  generated  de  novo  from 
membrane constituents before release (1,  2).  While several types of pharmaco- 
logical  agents  and  other  inhibitors  suppress  differentially the  release  of pre- 
formed or newly generated mediators from mast cells (3), immunological chal- 
lenge and IgE-independent activation of mast cells appear to stimulate without 
preference  the  release  of both  classes  of mediators.  The  availability  of dog 
mastocytoma cells of high purity that release histamine and leukotrienes (LT) 1 
B4, C4, and D4 in response to antigen and ionophore A23187 (4, 5), has permitted 
an initial comparative analysis of the specificity of activation of the two compart- 
ments of mediators by distinct stimuli. 
Materials and Methods 
Bovine plasma albumin-fraction V, bovine gamma-globulin, histamine diphosphate, kits 
for the quantification of lactic  acid dehydrogenase activity, penicillin G, streptomycin, 
compound 48/80 (Sigma Chemical Co., St. Louis, MO), recrystallized ovalbumin (Miles 
Laboratories, Elkhart, IN), calcium ionophore A23187, which was stored at -20°C as a 
3 mM stock solution in dimethylsulfoxide  (Calbiochem Corp., LaJolla, CA), polyethylene 
glycol (mol wt 3,000-3,700)  (MCB Manufacturing Chemists, Inc., Cincinnati, OH), O- 
phthalaldehyde (Dionex Co., Sunnyvale, CA), Joklik-modified minimum essential medium 
(MEM; Grand Island Biological Co., Grand Island, NY), Hydrofluor scintillation counting 
fluid (National  Diagnostics,  Somerville,  N  J),  short  ragweed  (Ambrosia  elatior) pollen 
extract (Hollister-Steir Co., Spokane, WA), amphotericin B with deoxycholate (Funga- 
zone, E.R. Squibb & Sons, La Miranda, CA), protease-free collagenase (CLSPA, Worthing- 
ton Biochemical Co.,  Freehold,  N  J),  arachidonic acid (Supelco,  Inc., Bellefonte, PA), 
[ 14,15-3H(N)]-leukotriene  C4 (34.0 Ci/mmol) (New England Nuclear, Inc., Boston, MA), 
and organic solvents that had been redistilled from glass (HPLC grade) (Burdick and 
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Jackson Laboratories, Inc., Muskegon, MI) were obtained from the designated suppliers. 
Synthetic leukotrienes B4, C4, and D4 were kindly provided by Dr. J. Rokach of Merck- 
Frosst  Laboratories,  Dorval,  Canada.  12-hydroxy-eicosatetraenoic acid  (12-HETE) and 
15-hydroperoxy-eicosatetraenoic acid (15-HPETE) were prepared and characterized as 
described (6, 7). Synthetic 15-HETE was a gift from Dr. E.J. Corey of Harvard University, 
Cambridge,  MA.  [3H]-Leukotriene B4  (specific activity 26.2  4-  5.9  Ci/mmol,  mean  4- 
range, n = 5) and [SH]-12-HETE (specific activity -- 11.7 4- 8.4 Ci/mmol) were generated 
from  [5,6,8,9,11,12,14,15-3H(N)]  arachidonic  acid  (specific  activity  60-100  Ci/mmol 
(New England Nuclear, Inc. Boston, MA) and purified as described (8, 9). The carboxy- 
terminal dodecapeptide of human  platelet  factor 4  (PF4(59-70)),  Leu-Tyr-Lys-Lys-Ile- 
Ile-Lys-Lys-Leu-Leu-Glu-Ser,  was prepared by standard solid-phase synthesis, purified by 
sequential counter-current distribution and filtration on Sephadex G-25 in 0.5 M NHaOH, 
and characterized by amino acid analysis and sequence determination (10).  Histamine in 
supernates  and  cell  pellets  of  mastocytoma suspensions  was  quantified  by  a  manual 
fluorimetric method, utilizing a standard curve of the values obtained from 5-200 ng/ 
ml of histamine (11). 
Preparation, Sensitization, and Activation of Dog Mastocytoma Cells.  Subcutaneous nodules 
of mastocytoma tissue were removed from a dog under general anesthesia (acepromazine 
maleate, Ayerst Laboratories, New York, NY and sodium thiamylal, Bio-Centric, Inc., St. 
Joseph, MO), freed of connective tissue, and minced with scissors into fragments of ~  1- 
mm diameter (4,  5).  The fragments were washed and resuspended in 20 ml of calcium- 
free MEM with 25 mM Hepes (pH 7.4) without (unsensitized) or with (sensitized) 5 ml of 
dog IgE-rich byperimmune anti-short ragweed serum, and incubated in a  10-cm diameter 
plastic  petri  dish  for  16-18  h  at  room  temperature.  It  has  been  demonstrated  that 
incubation with IgE before dispersion of the mastocytoma cells did not provide sufficient 
sensitization for a maximal response to antigen, but did enhance the responses achieved 
by resensitization and antigen challenge of isolated cells,  presumably by preserving IgE 
receptors (5).  Both sets of fragments were treated for 60 rain at 37°C with 80 U/ml of 
collagenase in order to disperse the mastocytoma cells (4, 5). The residual fragments were 
filtered  through  cheesecloth  and  the  filtrate  was  centrifuged  at  400  g  for  10  min  to 
recover mastocytoma cells of 93-97% purity, as assessed by staining with toluidine blue, 
and  viability  of 94%  or  greater;  minor  contaminants  consisted  of equal  numbers  of 
eosinophils,  macrophages, and  fibroblasts.  Replicate aliquots  of  106  mastocytoma cells 
from the respective sets were resuspended and incubated for 4 h at room temperature in 
1.0  ml of calcium-free Tyrode's buffer without or with a  1/10 dilution of the anti-short 
ragweed serum, washed twice, and resuspended in 1 ml of complete Tyrode's buffer with 
0.1  g/100 ml of ovalbumin before incubation for 2-45 rain at 37°C without or with  10 
pnu/ml of short ragweed pollen extract. Unsensitized mastocytoma cells were challenged 
similarly  with  0.2-2  tiM  calcium  ionophore  A23187,  0.1-1.0  ~g/ml  of  compound 
48/80, 0.1-3.0 #g/ml of 15-HETE, and  10 -6 M-10 -4 M PF4(59-70). 
Ident~cation and Quantification of Lipoxygenase Products of  Arachidonic Acid.  Each suspen- 
sion was centrifuged for  1 min at  10,000 g and one-fifth of the supernate was saved in 
two  equal  aliquots  at  -70°C  for  radioimmunoassays.  The  lipoxygenase  products  of 
arachidonic acid  were recovered from the remainder of each suspension by extraction 
with 2 ml of chloroform/methanol (2:1, vol/vol) twice and 2 ml of ethyl ether after the 
addition of 20,000 cpm of [ZH]-I  2-HETE. The extracts were pooled, dried under nitrogen 
to ~10 #1, diluted to  150 #1 with methanol/water/glacial acetic acid (60:40:0.03,  vol/ 
vol), and subjected to reverse-phase high performance liquid  chromatography (HPLC) 
with a  10-t~m octadecylsilane (ODS; Ultrasil, Altex Scientific Co., Beckman Instruments, 
Mountainview, CA) pre-column and a 4.6-mm x  25-cm column of 10/~m ODS that was 
developed  isocratically  with  methanol/water/glacial  acetic  acid  (70:30:0.03,  vol/vol; 
adjusted to pH 6.0 with concentrated ammonium hydroxide) at a  flow rate of 1.7  mt/ 
min (5). The leukotrienes were identified initially by elution at the same times as authentic 
standards. LTB~ and the C-6 peptide leukotrienes were quantified by the optical density 
at  270  nm  and  280 .nm,  respectively, relative  to  that of known  amounts of standard 
compounds (5).  The retention times of synthetic standards were:  LTC4 =  4.7-5.3  min GOETZL  ET  AL.  733 
(range, n = 8), LTD4 = 8.1-8.8 min, and LTB4 = 9.8-10.7 min. The amounts of [~H]- 
12-HETE in the eluates were measured and utilized to calculate the percentage recovery 
of the products. 
Radioimmunoassays of LTC4 and LTB4.  The assays were performed as described (12), 
except that the final dilution of anti-LTB4 plasma was 1/150, whereas that of anti-LTC4 
plasma was 1/1,050.  Each of triplicate tubes contained 0.2 ml of 0.05 M Tris-HCl (pH 
8.0), 0.1  ml of radioligand  (10,000 cpm), 0.1  ml of standard compound or unknown in 
Tris buffer, 0.2  ml of 5 mg/ml bovine gamma-globulin in Tris buffer, and 0.1  ml of 
diluted antiplasma.  One  set of tubes  received  0.1  ml  of additional  buffer instead  of 
antiplasma for the determination of total radioactivity. After the mixtures were incubated 
for 60  rain at room temperature and  15 rain at 0°C,  0.7  ml of 25% (w/vol) aqueous 
polyethylene glycol at 0°C was added to each tube. After vigorous mixing, the tubes were 
centrifuged at  1,400 g  for 60  min  at 4°C  and  1-ml aliquots of the supernates  were 
transferred to vials containing 10 ml of Hydrofluor for quantification  of radioactivity. 
The assays  for LTB4 and LTC4 were of  similar sensitivity  and specificity;  50% displacement 
of the respective radioligands required 0.1  ng of LTB4 and 0.2 ng of LTC4, while the 
cross-reactivity of either antiplasma with the other class of leukotrienes was <1% (12). 
Results 
Dog mastocytoma cells  were challenged with a  range of structurally distinct 
stimuli  of histamine  release  in  order  to  examine  the  concurrent  effects  on 
leukotriene generation.  Preliminary studies indicated that the  time course  of 
generation of LTC4 by mastocytoma cells was a function of the specific stimulus. 
HPLC analysis of the LTC4 produced by mastocytoma cells incubated at 37°C 
with ragweed antigen, 0.2 #M ionophore A23187,  10 ~tM PF4(59-70),  0.3 ~tg/ 
ml of compound 48/80, and buffer alone revealed the release of a mean (n =  2) 
of 18.4, 6.1, 4.7, 2.5, and 1.8 ng/106 mastocytoma cells,  respectively, at 1 min, 
19.2,  11.4, 7.3,  1.9, and 2.2 at 10 min,  19.8, 31.0, 9.5, 2.2, and 1.9 at 30 min, 
and  18.7,  26.9,  10.1,  2.4,  and 2.4  at 45  rain.  1 tsg/ml of 15-HETE, which is 
known to  modulate the activity of 5-1ipoxygenases (13,  14)  but had not been 
investigated in relation to histamine release from mast cells,  evoked the genera- 
tion of a mean (n =  2) of 6.4, 14.9, 26.1, and 28.2 ng of LTC4/106 mastocytoma 
cells at 1,  10, 30, and 45 rain, respectively, in the same experiments. 
The stimulus concentration-dependence of the generation of leukotrienes and 
of the  release  of histamine by  mastocytoma cells  then  was  defined for  each 
principle  with  a  standard  incubation  interval  of  30  min,  that  reflected  the 
maximum production of LTC4 with each stimulus.  15-HETE enhanced signifi- 
cantly the generation of leukotrienes at concentrations of 0.1-3 ~tg/ml, irrespec- 
tive  of whether  the  isolated  mediators  were  quantified by  optical  density or 
whether LTB4 and LTC4 were assessed by radioimmunoassay (Fig. 1).  15-HETE 
failed to evoke the release of histamine in amounts greater than that released 
spontaneously in  buffer.  In  contrast,  compound 48/80  did not stimulate the 
generation of leukotrienes at concentrations that released significant quantities 
of histamine (Fig. 2). Neither 15-HETE nor compound 48/80 was cytotoxic for 
mastocytoma cells,  as  evidenced by  their  failure to augment significantly the 
release of lactic acid dehydrogenase relative to that observed in  buffer alone 
(Figs.  1 and 2). The previously unrecognized selective activation of mast cells by 
15-HETE and 48/80, as reflected in the release of only one class of mediators, 
was not achieved by other IgE-independent stimuli or by antigen. In the same 
experiments ionophore A23187  (0.2  uM),  PF4(59-70)  (10  uM), and ragweed 734  SELECTIVE  STIMULATION  OF  MASTOCYTOMA  CELLS 
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FIGURE  1.  Selective generation and release of leukotrienes by mastocytoma cells challenged 
with 15-HETE. Each point and bracket depicts the mean -+ SD of the results of two (0.1 ~g/ 
ml of 15-HETE), three (1 and 3 ~g/ml), or four (buffer control and 0.3 t~g/ml) experiments 
for which  LTC4  (ll),  LTD4  (&),  and  LTB4  (11) were  purified by HPLC  and quantified by 
optical density. The mean levels of LTC4 (O) and LTB4 ([3) were determined in two of the 
experiments by  radioimmunoassays.  Each  bar  and  bracket  shows  the  mean  _+  SD  of the 
corresponding values for histamine release. The significance of the increases in the amounts 
of leukotrienes was assessed by a standard Student's t-test and is indicated by a  +  (P <  0.05) 
or an * (P <  0.01).  The release of lactic acid dehydrogenase by 0.3,  1, and 3 ~g/ml of 15- 
HETE  was  1.5  +_  0.9%  (mean  +  SD,  n  =  3),  2.5  _  1.0%,  and  3.0  _  1.4%,  respectively, 
compared to 2.1 -+ 0.6% in buffer alone. 
antigen resulted in the net release of 77.5 +  3.9% (mean +  SD, n  =  3), 21.9 _+ 
2.9%, and 18.7 +  2.4%, respectively, of the histamine in 106 mastocytoma cells, 
and evoked the generation of 21.2 -+ 5.5, 9.1  ±  5.1, and 16.4 ±  3.4 ng of LTC4 
(mean +  SD, n  -- 3), 4.8 ±  0.6, 3.2 ±  2.5, and 3.7 _+  1.6 ng of LTD4, and 10.6 
±  2.0, 6.1  +  2.9, and 9.5 _+ 2.3 ng of LTB4 by 106 mastocytoma cells (P <  0.05 
for all values relative to buffer controls, except the generation of LTD4 with 
PF4(59-70)). The specificity of the stimulation of leukotriene generation by 15- 
HETE was established by the lack of effect of 0.3-3  #g/ml of 15-HPETE and 
the lesser effect of 12-HETE,  1 #g/ml of which evoked the generation of a mean 
of 1.2,  2.7, and 4.9 ng of LTC4 at 1,  10, and 30 min (n -- 2), relative to 1.7,  1.9, 
and 2.1  ng with buffer alone. GOETZL  ET  AL.  735 
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FIGURE  2.  Selective release of histamine by mastocytoma cells challenged with 48/80.  Each 
point or bar and bracket depicts the mean +  SD of the results of three experiments, in which 
the analyses were performed with the same techniques as noted in  Fig.  1.  The symbols for 
each  mediator and  for statistical significance also are the same as in  Fig.  1.  The release of 
lactic acid dehydrogenase by 0.1, 0.3, and  1 ~g/ml of 48/80 was 2.3 _+ 1.4% (mean _+ S.D., n 
=  3), 2.5 ___ 0.9e/c, and 3.6 +_. 0.6% respectively, compared to 2.1  +  0.6% in buffer alone. 
Discussion 
The  exposure  of IgE-sensitized  dog  mastocytoma cells  to  antigen  and  of 
unsensitized mastocytoma cells to ionophore A23187 or PF4(59-70)  stimulates 
both the release of histamine and the generation and release of LTB4,  LTC4, 
and  LTD4.  In  contrast,  the  interaction  of mastocytoma cells  with  15-HETE 
stimulates selectively the generation of leukotrienes, in the absence of histamine 
release, while compound 48/80  releases histamine without enhancing the gen- 
eration of leukotrienes. The stimulation of leukotriene generation was significant 
at concentrations of 15-HETE of 0.1  ttg/ml or higher and reached a plateau at 
1-3/xg/ml (Fig.  1).  The types and maximal quantities of leukotrienes released 
by mastocytoma cells exposed to 15-HETE were not substantially different from 
those released by mastocytoma cells challenged with optimal concentrations of 
antigen or ionophore A23187 (5). Although the mechanism of enhancement of 
leukotriene generation by  15-HETE was not investigated, neither of the struc- 
turally related principles 15-HPETE nor 12-HETE possessed the same capacity. 
Compound 48/80 elicited a concentration-dependent release of histamine, that 
was similar in magnitude to the release evoked by antigen or ionophore A23187, 
but failed to stimulate the generation of ieukotrienes (Fig. 2). 
That  natural  stimuli  are  capable  of activating  only  one  compartment  of 
mediators suggests either that some subsets of mast cell receptors are coupled 
selectively to a restricted synthetic or secretory response or that such stimuli are 
incapable of initiating the sequence of biochemical events required for a complete 
response.  Although  it  may be  simpler  to  postulate  a  selective stimulation  of 736  SELECTIVE STIMULATION OF  MASTOCYTOMA CELLS 
mastocytoma cells,  the  data presented do  not exclude the possibility that  15- 
HETE and compound 48/80 might stimulate both compartments of mediators 
and concurrently inhibit the release of histamine and the generation or release 
of leukotrienes, respectively.  Nonetheless, effectively selective stimuli may be 
useful probes in investigations of the cellular prerequisites for mediator genera- 
tion and release. If mast cell activation in vivo is similarly selective, then it will 
be possible to examine separately the systemic and local organ effects of granule- 
associated and newly generated mediators, in the absence of the other class of 
mediators. 
Summary 
Isolated  dog  mastocytoma cells  sensitized  with  dog  anti-ragweed  IgE  and 
challenged with ragweed antigen or incubated with ionophore A23187  or the 
carboxy-terminal dodecapeptide of platelet factor 4,  PF4(59-70),  release hista- 
mine and concurrently generate leukotrienes B4,  C4,  and D4.  In contrast, the 
exposure of mastocytoma cells to  0.1-3  #g/ml of 15-hydroxyeicosatetraenoic 
acid  (15-HETE)  stimulates  selectively the  generation  of leukotrienes,  in  the 
absence of histamine release, while 0.1-1  #g/ml of compound 48/80  releases 
histamine without enhancing the generation of leukotrienes. That natural stimuli 
are capable of selectively activating one synthetic or secretory compartment of 
mast cells suggests that separate subsets of receptors as well as different biochem- 
ical events may serve to mobilize each class of mediators. 
Received  for publication 28 March 1983 and in revised  form 25 May 1983. 
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